25/09/2017
M&S Decisions attended the 3rd AstraZeneca-MedImmune-CRUK Cancer Symposium, Cambridge, the UK.
Kirill Peskov, CEO of M&S Decisions, presented the work “Radiation and anti-PD-(L)1 treatment combinations: Immune cell responses and dose scheduling optimization using a joint experimental and systems modeling approach” made by M&S Decisions in collaboration with AstraZeneca and MedImmune.
